Edgewise Therapeutics
EWTX
EWTX
129 hedge funds and large institutions have $1.67B invested in Edgewise Therapeutics in 2024 Q1 according to their latest regulatory filings, with 32 funds opening new positions, 59 increasing their positions, 29 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
129
Holders Change
+13
Holders Change %
+11.21%
% of All Funds
1.87%
Holding in Top 10
5
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+66.67%
% of All Funds
0.07%
New
32
Increased
59
Reduced
29
Closed
19
Calls
$408K
Puts
$270K
Net Calls
+$138K
Net Calls Change
-$153K
Top Buyers
| 1 |
RCM
RA Capital Management
Boston,
Massachusetts
|
+$163M |
| 2 |
BBA
Baker Bros. Advisors
New York
|
+$49.7M |
| 3 |
PBA
Paradigm Biocapital Advisors
New York
|
+$44.6M |
| 4 |
TCM
TCG Crossover Management
Palo Alto,
California
|
+$41.5M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$34.5M |
Top Sellers
| 1 |
NHAS
Novo Holdings A/S
Hellerup,
Denmark
|
-$66.4M |
| 2 |
Viking Global Investors
Stamford,
Connecticut
|
-$51.4M |
| 3 |
EC
EcoR1 Capital
San Francisco,
California
|
-$40.9M |
| 4 |
DTC
Deep Track Capital
Greenwich,
Connecticut
|
-$27.8M |
| 5 |
DM
Deerfield Management
New York
|
-$19.3M |
